The Coronavirus Treatment Acceleration Program (CTAP) is a special emergency program created by the FDA. It uses every available method to move new treatments to patients as quickly as possible, while at the same time finding out whether they are helpful or harmful.

The FDA continues to support clinical trials that are testing new treatments for COVID-19 to gain valuable knowledge about their safety and effectiveness.

Further information at: